Table 1

Baseline characteristics of all participating patients

ValueAll patients
n=96
Demographic information
Age (years), mean±SD61.3±14.7
Ethnicity, n (%)Dutch88 (91.7)
Other8 (8.3)
Educational level, n (%)High school or less36 (37.5)
Vocational25 (26.05)
Higher vocational or university34 (35.5)
Unknown1 (1.0)
Single7 (7.3)
Marital state, n (%)Married or cohabiting65 (67.7)
Widowed13 (13.5)
Divorced9 (9.4)
Living apart together2 (2.1)
Children at home n (%) <17 years old, n (%)16 (16.7)
Distance to the hospital in km, n (%)0–10 km21 (21.9)
10–50 km48 (50.0)
>50 km27 (28.1)
Clinical information
Patients with recurrent disease, n (%)15 (15.6)
Diagnosis presurgery, n (%)Ovarian cancer17 (17.7)
Endometrial cancer21 (21.9)
Vulvar cancer22 (22.9)
Cervical cancer14 (14.6)
Suspected cancer22 (21.9)
Stage after surgery, n (%)Undefined*5 (5.2)
Stage I39 (40.6)
Stage II8 (8.3)
Stage III17 (17.7)
Stage IV4 (4.2)
Benign11 (11.5)
Borderline tumour ovary5 (5.2)
Metastasised non-gynaecological tumour†1 (1.0)
Not appplicable‡5 (5.2)
Type of surgery, n (%)Radical hysterectomy with PLND11 (11.5)
Laparoscopic salpingo-oophorectomy2 (2.1)
Staging surgery8 (8.2)
Primary debulking surgery14 (14.6)
Abdominal hysterectomy7 (7.3)
Exploratory laparotomy20 (20.8)
Total laparoscopic or robot assisted hysterectomy8 (8.4)
WLE/Radical vulvectomy21 (21.9)
Robot-assisted staging surgery5 (5.2)
  • Mean ± standard deviation or number in the group is shown. Abbreviations: PLND = pelvic lymph node dissection; WLE=Wide local excision.

  • *Stage was classified as undefined if there was insufficient information after surgery for classification of FIGO stage.

  • †Krukenberg tumour

  • ‡Consists of recurrent disease without proper staging afterwards